Rigorous Risk Control for Cytotoxic Drugs
Our injectables team brings innovative cancer treatments from the laboratory to the public in safe, effective forms with the utmost attention to product quality and safety.
- PIC/S GMP certified facility in Yunlin, Taiwan
- Recently launched, Taiwan FDA approved and US FDA certification expected early 2023
- Specializes in cytotoxic oncology drugs
- Utilizes best-in-class technologies and sterilization processes to meet the high product quality and safety standards of this complex market
- 123,318 square feet
- Trade Agreement Act compliance meets U.S. requirements for trade with the U.S. government